Bone morphogenetic protein-3 is a negative regulator of bone density

[1]  I. Schieren,et al.  Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation , 2000, Nature Genetics.

[2]  K. Lyons,et al.  The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. , 2000, Development.

[3]  Y. Iwamoto,et al.  Inhibitory effects of activin‐a on osteoblast differentiation during cultures of fetal rat calvarial cells , 1999, Journal of cellular biochemistry.

[4]  R. Derynck,et al.  Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. , 1999, Development.

[5]  C. Heldin,et al.  Functional antagonism between activin and osteogenic protein‐1 in human embryonal carcinoma cells , 1999, Journal of cellular physiology.

[6]  A. Lawler,et al.  Characterization of GDF-10 expression patterns and null mice. , 1999, Developmental biology.

[7]  A. Nordheim,et al.  Id Genes Are Direct Targets of Bone Morphogenetic Protein Induction in Embryonic Stem Cells* , 1999, The Journal of Biological Chemistry.

[8]  P. Hoodless,et al.  Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2* , 1998, The Journal of Biological Chemistry.

[9]  Ken W. Y. Cho,et al.  Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. , 1997, Development.

[10]  P. Hoodless,et al.  MADR1, a MAD-Related Protein That Functions in BMP2 Signaling Pathways , 1996, Cell.

[11]  K. Kangawa,et al.  Identification of rat bone morphogenetic protein-3b (BMP-3b), a new member of BMP-3. , 1996, Biochemical and biophysical research communications.

[12]  R. Derynck,et al.  Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype , 1996, The Journal of cell biology.

[13]  R. Maxson,et al.  Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  V. Rosen,et al.  Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype , 1995, Molecular and cellular biology.

[15]  A. Weiland,et al.  Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[16]  N. Ueno,et al.  Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. , 1995, Biochemical and biophysical research communications.

[17]  R. Harland,et al.  The transforming growth factor beta family and induction of the vertebrate mesoderm: bone morphogenetic proteins are ventral inducers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Gelbart,et al.  Characterization and relationship of dpp receptors encoded by the saxophone and thick veins genes in Drosophila , 1994, Cell.

[19]  J. Massagué,et al.  Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor , 1994, Cell.

[20]  J. Massagué,et al.  Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.

[21]  Professor Gregory R. Mundy,et al.  Physiology and Pharmacology of Bone , 1993, Handbook of Experimental Pharmacology.

[22]  V. Rosen,et al.  Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. , 1992, Endocrinology.

[23]  F. Luyten,et al.  Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures. , 1992, The Journal of biological chemistry.

[24]  E. Canalis,et al.  Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone , 1991, Molecular and cellular biology.

[25]  F. Luyten,et al.  Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. , 1989, The Journal of biological chemistry.

[26]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  N. Takahashi,et al.  Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage , 2002 .

[28]  K. Lyons,et al.  Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. , 2000, Human gene therapy.

[29]  J. Cauley,et al.  Recent progress in understanding the genetic susceptibility to osteoporosis , 1999, Genetic epidemiology.

[30]  William C. Smith.  TGFβ inhibitors: new and unexpected requirements in vertebrate development , 1999 .